MedPath
NMPA Approval

复方氨基酸注射液 (14 aa-sf)

国药准字H20023293

August 26, 2024

国药准字H20023293

Drug Information

复方氨基酸注射液 (14 aa-sf)

注射剂

250ml:21.2g(总氨基酸)

化学药品

August 26, 2024

Company Information

Applicant Company

湖北省荆州市监利市城东工业园(容城镇玉沙大道工业区285号)

Manufacturing Company

湖北省荆州市监利市城东工业园(容城镇玉沙大道工业区285号)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方氨基酸注射液 (14 aa-sf) - NMPA 批准文号 | MedPath